Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Regadenoson

A selective adenosine A2A receptor agonist that dilates the coronary arteries: approved in the United States in 2008, it is used as a pharmacological stress agent in myocardial perfusion imaging for people who cannot exercise adequately. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.

Did you know?It is a derivative of adenosine carrying an extra pyrazole ring: compared with the natural molecule, whose half-life is about ten seconds, it has a biological half-life of 2-3 minutes.

RegadenosonGo to the active ingredient →
RegadenosonActive ingredientRegadenosonCat. No. P-R025-001CAS 313348-27-5
DhaprImpurityDhaprCat. No. P-R025-021CAS 16033-28-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.